Anthracycline chemotherapy, Vascular Dysfunction and Cognitive Impairment: Burgeoning Topics and Future Directions

References

• Benjamin EJ , ViraniSS, CallawayCWet al. Heart Disease and Stroke Statistics-2018 update: a report from the American Heart Association. Circulation, 137(12), e67–e492 (2018).
   PubMed Web of Science ®Google Scholar
• Paterson DI , WiebeN, CheungWYet al. Incident cardiovascular disease among adults with cancer: a population-based cohort study. JACC CardioOncol., 4(1), 85–94 (2022).
   PubMedGoogle Scholar
• Aboumsallem JP , MoslehiJ, de BoerRA. Reverse cardio-oncology: cancer development in patients with cardiovascular disease. J. Am. Heart Assoc., 9(2), e013754 (2020).
   PubMed Web of Science ®Google Scholar
• Valero-Elizondo J , ChouairiF, KheraRet al. Atherosclerotic cardiovascular disease, cancer, and financial toxicity among adults in the United States. JACC CardioOncol., 3(2), 236–246 (2021).
   PubMedGoogle Scholar
• Roth GA , MensahGA, JohnsonCOet al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J. Am. Coll. Cardiol., 76(25), 2982–3021 (2020).
   PubMed Web of Science ®Google Scholar
• Cardiovascular diseases. World Health Organization (2021). https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
   Google Scholar
• Guzik A , BushnellC. Stroke epidemiology and risk factor management. Continuum (Minneap Minn), 23(1, Cerebrovascular Disease), 15–39 (2017).
   PubMedGoogle Scholar
• Groenewegen A , RuttenFH, MosterdA, HoesAW. Epidemiology of heart failure. Eur. J. Heart Fail., 22(8), 1342–1356 (2020).
   PubMed Web of Science ®Google Scholar
• Ovbiagele B , Nguyen-HuynhMN. Stroke epidemiology: advancing our understanding of disease mechanism and therapy. Neurotherapeutics, 8(3), 319–329 (2011).
   PubMed Web of Science ®Google Scholar
• Roy PS , SaikiaBJ. Cancer and cure: a critical analysis. Indian J. Cancer, 53(3), 441–442 (2016).
   PubMed Web of Science ®Google Scholar
• What is Cancer? In: National Cancer Institute.National Institutes of Health (2021). https://www.cancer.gov/about-cancer/understanding/what-is-cancer#:~:text=Cancer%20is%20a%20disease%20in,up%20of%20trillions%20of%20cells
   Google Scholar
• Golemis EA , ScheetP, BeckTNet al. Molecular mechanisms of the preventable causes of cancer in the United States. Genes Dev., 32(13-14), 868–902 (2018).
   PubMed Web of Science ®Google Scholar
• Lewandowska AM , RudzkiM, RudzkiS, LewandowskiT, LaskowskaB. Environmental risk factors for cancer - review paper. Ann. Agric. Environ. Med., 26(1), 1–7 (2019).
   PubMed Web of Science ®Google Scholar
• Seals DR , JusticeJN, LaRoccaTJ. Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity. J. Physiol., 594(8), 2001–2024 (2016).
   PubMed Web of Science ®Google Scholar
• Heart Disease Facts . Centers for Disease Control and Prevention (2022). https://www.cdc.gov/heartdisease/facts.htm
   Google Scholar
• Health Topics - Heart disease and heart attack. In: Office of the Associate Director for Policy and Strategy.Center for Disease Control and Prevention (2022). https://www.cdc.gov/policy/polaris/healthtopics/heartdisease/index.html
   Google Scholar
• Santucci C , CarioliG, BertuccioPet al. Progress in cancer mortality, incidence, and survival: a global overview. Eur. J. Cancer Prev., 29(5), 367–381 (2020).
   PubMed Web of Science ®Google Scholar
• Cancer Data and Statistics. In: Cancer.Centers for Disease Control and Prevention (2022). https://www.cdc.gov/cancer/dcpc/data/index.htm
   Google Scholar
• Halpern MT , YabroffKR. Prevalence of outpatient cancer treatment in the United States: estimates from the Medical Panel Expenditures Survey (MEPS). Cancer Invest., 26(6), 647–651 (2008).
   PubMed Web of Science ®Google Scholar
• Ewald JA , DesotelleJA, WildingG, JarrardDF. Therapy-induced senescence in cancer. J. Natl Cancer Inst., 102(20), 1536–1546 (2010).
   PubMedGoogle Scholar
• Schmitt CA , WangB, DemariaM. Senescence and cancer - role and therapeutic opportunities. Nat. Rev. Clin. Oncol., 19(10), 619–636 (2022).
   PubMed Web of Science ®Google Scholar
• Meredith AM , DassCR. Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. J. Pharm. Pharmacol., 68(6), 729–741 (2016).
   PubMed Web of Science ®Google Scholar
• Zamel ON , InocianEP, AlshehryAS, TumalaRB, PatalagsaJG, AlsalehKA. Quality of life among breast and colon cancer patients before and after first-cycle chemotherapy. J. Holist. Nurs., 39(2), 116–125 (2021).
   PubMed Web of Science ®Google Scholar
• Jacobs JM , ReamME, PensakNet al. Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life. J. Natl Compr. Canc. Netw., 17(3), 221–228 (2019).
   PubMed Web of Science ®Google Scholar
• Institute NC . Cancer Statistics.National Institutes of Health (2020). https://www.cancer.gov/about-cancer/understanding/statistics
   Google Scholar
• Minotti G , MennaP, SalvatorelliE, CairoG, GianniL. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev., 56(2), 185–229 (2004).
   PubMed Web of Science ®Google Scholar
• Kaklamani VG , GradisharWJ. Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer?Clin. Breast Cancer, 4(Suppl. 1), S26–S33 (2003).
   PubMedGoogle Scholar
• Fujita N , FujitaK, KimSJet al. Response-guided omission of anthracycline in patients with HER2-positive early breast cancer treated with neoadjuvant taxane and trastuzumab: 5-year follow-up of prognostic study using propensity score matching. Oncology, 100(5), 257–266 (2022).
   PubMed Web of Science ®Google Scholar
• Gewirtz DA . A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol., 57(7), 727–741 (1999).
   PubMed Web of Science ®Google Scholar
• Meinardi MT , GietemaJA, van VeldhuisenDJ, vander Graaf WT, de VriesEG, SleijferDT. Long-term chemotherapy-related cardiovascular morbidity. Cancer Treat. Rev., 26(6), 429–447 (2000).
   PubMed Web of Science ®Google Scholar
• Khanna A , PequenoP, GuptaSet al. Increased risk of all cardiovascular disease subtypes among childhood cancer survivors: population-based matched cohort study. Circulation, 140(12), 1041–1043 (2019).
   PubMed Web of Science ®Google Scholar
• Ganz PA , GoodwinPJ. Breast cancer survivorship: where are we today?Adv. Exp. Med. Biol., 862, 1–8 (2015).
   PubMed Web of Science ®Google Scholar
• Chatterjee K , ZhangJ, HonboN, KarlinerJS. Doxorubicin cardiomyopathy. Cardiology, 115(2), 155–162 (2010).
   PubMed Web of Science ®Google Scholar
• Bhagat A , KleinermanES. Anthracycline-induced cardiotoxicity: causes, mechanisms, and prevention. Adv. Exp. Med. Biol., 1257, 181–192 (2020).
   PubMed Web of Science ®Google Scholar
• Vuong JT , Stein-MerlobAF, ChengRK, YangEH. Novel therapeutics for anthracycline induced cardiotoxicity. Front. Cardiovasc. Med., 9, 863314 (2022).
   PubMed Web of Science ®Google Scholar
• Luu AZ , ChowdhuryB, Al-OmranM, TeohH, HessDA, VermaS. Role of endothelium in doxorubicin-induced cardiomyopathy. JACC Basic Transl. Sci., 3(6), 861–870 (2018).
   PubMedGoogle Scholar
• Lakatta EG , LevyD. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation, 107(1), 139–146 (2003).
   PubMed Web of Science ®Google Scholar
• Parr SK , LiangJ, SchadlerKL, GilchristSC, SteeleCC, AdeCJ. Anticancer therapy-related increases in arterial stiffness: a systematic review and meta-analysis. J. Am. Heart Assoc., 9(14), e015598 (2020).
   PubMed Web of Science ®Google Scholar
• Budinskaya K , PuchnerováV, SvačinováJet al. Non-invasive assessment of vascular system function and damage induced by anthracycline treatment in the pediatric cancer survivors. Physiol. Res., 66(Suppl. 4), S553–S560 (2017).
   PubMedGoogle Scholar
• Terwoord JD , BeyerAM, GuttermanDD. Endothelial dysfunction as a complication of anti-cancer therapy. Pharmacol. Ther., 237, 108116 (2022).
   PubMed Web of Science ®Google Scholar
• Adji A , O’RourkeMF, NamasivayamM. Arterial stiffness its assessment, prognostic value, and implications for treatment. Am. J. Hypertens., 24(1), 5–17 (2011).
   PubMed Web of Science ®Google Scholar
• Mitchell GF , HwangSJ, VasanRSet al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation, 121(4), 505–511 (2010).
   PubMed Web of Science ®Google Scholar
• Cahill PA , RedmondEM. Vascular endothelium - Gatekeeper of vessel health. Atherosclerosis, 248, 97–109 (2016).
   PubMed Web of Science ®Google Scholar
• Celermajer DS , SorensenKE, BullC, RobinsonJ, DeanfieldJE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J. Am. Coll. Cardiol., 24(6), 1468–1474 (1994).
   PubMed Web of Science ®Google Scholar
• Cosentino F , RubattuS, SavoiaC, VenturelliV, PagannonneE, VolpeM. Endothelial dysfunction and stroke. J. Cardiovasc. Pharmacol., 38(Suppl. 2), S75–S78 (2001).
   PubMed Web of Science ®Google Scholar
• Seals DR , JablonskiKL, DonatoAJ. Aging and vascular endothelial function in humans. Clin. Sci. (Lond)., 120(9), 357–375 (2011).
   PubMed Web of Science ®Google Scholar
• Clayton ZS , BruntVE, HuttonDAet al. Doxorubicin-induced oxidative stress and endothelial dysfunction in conduit arteries is prevented by mitochondrial-specific antioxidant treatment. JACC CardioOncol., 2(3), 475–488 (2020).
   PubMedGoogle Scholar
• Gioscia-Ryan RA , ClaytonZS, ZiglerMCet al. Lifelong voluntary aerobic exercise prevents age- and Western diet- induced vascular dysfunction, mitochondrial oxidative stress and inflammation in mice. J. Physiol., 599(3), 911–925 (2021).
   PubMed Web of Science ®Google Scholar
• Rossman MJ , Gioscia-RyanRA, Santos-ParkerJRet al. Inorganic nitrite supplementation improves endothelial function with aging: translational evidence for suppression of mitochondria-derived oxidative stress. Hypertension, 77(4), 1212–1222 (2021).
   PubMed Web of Science ®Google Scholar
• Brunt VE , Gioscia-RyanRA, CassoAGet al. Trimethylamine-N-oxide promotes age-related vascular oxidative stress and endothelial dysfunction in mice and healthy humans. Hypertension, 76(1), 101–112 (2020).
   PubMed Web of Science ®Google Scholar
• Green D . Point: flow-mediated dilation does reflect nitric oxide-mediated endothelial function. J. Appl. Physiol. (1985), 99(3), 1233–1234 (2005).
   PubMed Web of Science ®Google Scholar
• Tabas I , García-CardeñaG, OwensGK. Recent insights into the cellular biology of atherosclerosis. J. Cell Biol., 209(1), 13–22 (2015).
   PubMed Web of Science ®Google Scholar
• Chirinos JA , SegersP, HughesT, TownsendR. Large-artery stiffness in health and disease: JACC state-of-the-art review. J. Am. Coll. Cardiol., 74(9), 1237–1263 (2019).
   PubMed Web of Science ®Google Scholar
• Waldstein SR , RiceSC, ThayerJF, NajjarSS, ScuteriA, ZondermanAB. Pulse pressure and pulse wave velocity are related to cognitive decline in the Baltimore longitudinal study of aging. Hypertension, 51(1), 99–104 (2008).
   PubMed Web of Science ®Google Scholar
• Pase MP , BeiserA, HimaliJJet al. Aortic stiffness and the risk of incident mild cognitive impairment and dementia. Stroke, 47(9), 2256–2261 (2016).
   PubMed Web of Science ®Google Scholar
• Wang MC , TsaiWC, ChenJY, HuangJJ. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am. J. Kidney Dis., 45(3), 494–501 (2005).
   PubMed Web of Science ®Google Scholar
• Butlin M , TanI, SpronckB, AvolioAP. Measuring arterial stiffness in animal experimental studies. Arterioscler. Thromb. Vasc. Biol., 40(5), 1068–1077 (2020).
   PubMed Web of Science ®Google Scholar
• Tanaka H , DinennoFA, MonahanKD, ClevengerCM, DeSouzaCA, SealsDR. Aging, habitual exercise, and dynamic arterial compliance. Circulation, 102(11), 1270–1275 (2000).
   PubMed Web of Science ®Google Scholar
• Dengel DR , NessKK, GlasserSP, WilliamsonEB, BakerKS, GurneyJG. Endothelial function in young adult survivors of childhood acute lymphoblastic leukemia. J. Pediatr. Hematol. Oncol., 30(1), 20–25 (2008).
   PubMed Web of Science ®Google Scholar
• Jang WJ , ChoiDY, JeonIS. Vascular endothelial dysfunction after anthracyclines treatment in children with acute lymphoblastic leukemia. Korean J. Pediatr., 56(3), 130–134 (2013).
   PubMedGoogle Scholar
• Lee K , KangI, MackWJet al. Effects of high-intensity interval training on vascular endothelial function and vascular wall thickness in breast cancer patients receiving anthracycline-based chemotherapy: a randomized pilot study. Breast Cancer Res. Treat., 177(2), 477–485 (2019).
   PubMed Web of Science ®Google Scholar
• Steeghs N , RabelinkTJ, op’tRoodt Jet al. Reversibility of capillary density after discontinuation of bevacizumab treatment. Ann. Oncol., 21(5), 1100–1105 (2010).
   PubMed Web of Science ®Google Scholar
• Chow AY , ChinC, DahlG, RosenthalDN. Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study. J. Clin. Oncol., 24(6), 925–928 (2006).
   PubMed Web of Science ®Google Scholar
• Jenei Z , BárdiE, MagyarMT, HorváthA, ParaghG, KissC. Anthracycline causes impaired vascular endothelial function and aortic stiffness in long term survivors of childhood cancer. Pathol. Oncol. Res., 19(3), 375–383 (2013).
   PubMed Web of Science ®Google Scholar
• Jones LW , HaykowskyM, PeddleCJet al. Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and/or trastuzumab. Cancer Epidemiol. Biomarkers Prev., 16(5), 1026–1031 (2007).
   PubMed Web of Science ®Google Scholar
• Chaosuwannakit N , D’AgostinoR, HamiltonCAet al. Aortic stiffness increases upon receipt of anthracycline chemotherapy. J. Clin. Oncol., 28(1), 166–172 (2010).
   PubMed Web of Science ®Google Scholar
• Rimessi A , PreviatiM, NigroF, WieckowskiMR, PintonP. Mitochondrial reactive oxygen species and inflammation: molecular mechanisms, diseases and promising therapies. Int. J. Biochem. Cell Biol., 81(Pt B), 281–293 (2016).
   PubMedGoogle Scholar
• Wallace KB , SardãoVA, OliveiraPJ. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ. Res., 126(7), 926–941 (2020).
   PubMed Web of Science ®Google Scholar
• Rossman MJ , Santos-ParkerJR, StewardCACet al. Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults. Hypertension, 71(6), 1056–1063 (2018).
   PubMed Web of Science ®Google Scholar
• Bikomeye JC , TerwoordJM, SantosJH, BeyerAM. Emerging mitochondrial signaling mechanisms in cardio-oncology: beyond oxidative stress. Am. J. Physiol. Heart Circ. Physiol., 323(4), H702–H720 (2022).
   PubMed Web of Science ®Google Scholar
• McCarthy CG , WenceslauCF, GoulopoulouSet al. Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats. Cardiovasc. Res., 107(1), 119–130 (2015).
   PubMed Web of Science ®Google Scholar
• Clayton ZS , BruntVE, HuttonDAet al. Tumor necrosis factor alpha-mediated inflammation and remodeling of the extracellular matrix underlies aortic stiffening induced by the common chemotherapeutic agent doxorubicin. Hypertension, 77(5), 1581–1590 (2021).
   PubMed Web of Science ®Google Scholar
• Moreau KL , DeaneKD, MeditzAL, KohrtWM. Tumor necrosis factor-α inhibition improves endothelial function and decreases arterial stiffness in estrogen-deficient postmenopausal women. Atherosclerosis, 230(2), 390–396 (2013).
   PubMed Web of Science ®Google Scholar
• Galarraga B , KhanF, KumarP, PullarT, BelchJJ. Etanercept improves inflammation-associated arterial stiffness in rheumatoid arthritis. Rheumatology (Oxford), 48(11), 1418–1423 (2009).
   PubMed Web of Science ®Google Scholar
• Clayton ZS , HuttonDA, MahoneySA, SealsDR. Anthracycline chemotherapy-mediated vascular dysfunction as a model of accelerated vascular aging. Aging Cancer, 2(1-2), 45–69 (2021).
   PubMedGoogle Scholar
• Russo M , BonoE, GhigoA. The interplay between autophagy and senescence in anthracycline cardiotoxicity. Curr. Heart Fail. Rep., 18(4), 180–190 (2021).
   PubMed Web of Science ®Google Scholar
• LaRocca TJ , HensonGD, ThorburnA, SindlerAL, PierceGL, SealsDR. Translational evidence that impaired autophagy contributes to arterial ageing. J. Physiol., 590(14), 3305–3316 (2012).
   PubMed Web of Science ®Google Scholar
• Prasanna PG , CitrinDE, HildesheimJet al. Therapy-induced senescence: opportunities to improve anticancer therapy. J. Natl Cancer Inst., 113(10), 1285–1298 (2021).
   PubMedGoogle Scholar
• Demaria M , O’LearyMN, ChangJet al. Cellular senescence promotes adverse effects of chemotherapy and cancer relapse. Cancer Discov., 7(2), 165–176 (2017).
   PubMed Web of Science ®Google Scholar
• Freund A , OrjaloAV, DesprezPY, CampisiJ. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med., 16(5), 238–246 (2010).
   PubMed Web of Science ®Google Scholar
• Blaser H , DostertC, MakTW, BrennerD. TNF and ROS crosstalk in inflammation. Trends Cell Biol., 26(4), 249–261 (2016).
   PubMed Web of Science ®Google Scholar
• Demaria M , OhtaniN, YoussefSAet al. An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev. Cell., 31(6), 722–733 (2014).
   PubMed Web of Science ®Google Scholar
• Hutton D , BruntV, MahoneySet al. Cellular senescence mediates doxorubicin-induced arterial dysfunction via activation of mitochondrial oxidative stress and the mammalian target of rapamycin. FASEB J., 35(S1), (2021).
   Google Scholar
• Mahoney S , HuttonD, RossmanMet al. Late-life treatment with the senolytic ABT-263 reverses aortic stiffening and improves endothelial function with aging. FASEB J., 35(S1), (2021).
   Google Scholar
• Mahoney S , VenkatasubramanianR, RossmanMet al. Fisetin supplementation improves age-related vascular endothelial function by suppressing cellular senescence and mitochondrial oxidative stress. FASEB J., 36(S1), (2022).
   Google Scholar
• Mounier NM , Abdel-MagedAE, WahdanSA, GadAM, AzabSS. Chemotherapy-induced cognitive impairment (CICI): an overview of etiology and pathogenesis. Life Sci., 258, 118071 (2020).
   PubMed Web of Science ®Google Scholar
• Aretouli E , BrandtJ. Everyday functioning in mild cognitive impairment and its relationship with executive cognition. Int. J. Geriatr. Psychiatry, 25(3), 224–233 (2010).
   PubMed Web of Science ®Google Scholar
• Rajan KB , WeuveJ, BarnesLL, McAninchEA, WilsonRS, EvansDA. Population estimate of people with clinical Alzheimer’s disease and mild cognitive impairment in the United States (2020–2060). Alzheimers Dement., 17(12), 1966–1975 (2021).
   PubMed Web of Science ®Google Scholar
• Sanford AM . Mild cognitive impairment. Clin. Geriatr. Med., 33(3), 325–337 (2017).
   PubMed Web of Science ®Google Scholar
• Jongsiriyanyong S , LimpawattanaP. Mild cognitive impairment in clinical practice: a review article. Am. J. Alzheimers Dis. Other Demen., 33(8), 500–507 (2018).
   PubMed Web of Science ®Google Scholar
• Ton TGN , DeLeireT, MaySGet al. The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment. Alzheimers Dement., 13(3), 217–224 (2017).
   PubMed Web of Science ®Google Scholar
• Cascella M , DiNapoli R, CarboneD, CuomoGF, BimonteS, MuzioMR. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives. Recenti. Prog. Med., 109(11), 523–530 (2018).
   PubMedGoogle Scholar
• Graff-Radford J . Vascular cognitive impairment. Continuum (Minneap Minn)., 25(1), 147–164 (2019).
   PubMedGoogle Scholar
• Iadecola C , DueringM, HachinskiVet al. Vascular cognitive impairment and dementia: JACC scientific expert panel. J. Am. Coll. Cardiol., 73(25), 3326–3344 (2019).
   PubMed Web of Science ®Google Scholar
• Csipo T , LipeczA, FulopGAet al. Age-related decline in peripheral vascular health predicts cognitive impairment. Geroscience, 41(2), 125–136 (2019).
   PubMed Web of Science ®Google Scholar
• Watson NL , Sutton-TyrrellK, RosanoCet al. Arterial stiffness and cognitive decline in well-functioning older adults. J. Gerontol. A Biol. Sci. Med. Sci., 66(12), 1336–1342 (2011).
   PubMed Web of Science ®Google Scholar
• Gorelick PB , CountsSE, NyenhuisD. Vascular cognitive impairment and dementia. Biochim. Biophys. Acta, 1862(5), 860–868 (2016).
   PubMed Web of Science ®Google Scholar
• Osterlundh G , BjureJ, LanneringB, KjellmerI, UvebrantP, MárkyI. Regional cerebral blood flow and neuron-specific enolase in cerebrospinal fluid in children with acute lymphoblastic leukemia during induction treatment. J. Pediatr. Hematol. Oncol., 21(5), 378–383 (1999).
   PubMed Web of Science ®Google Scholar
• Bailey TG , KleinT, MenesesALet al. Cerebrovascular function and its association with systemic artery function and stiffness in older adults with and without mild cognitive impairment. Eur. J. Appl. Physiol., 122(8), 1843–1856 (2022).
   PubMed Web of Science ®Google Scholar
• White Z , ParrS, TurpinV-R, HammondS, AdeC. Abstract 14119: aortic stiffness is associated with cognitive decline and cardiovascular disease manifestation in cancer survivors. Circulation, 144(A14119), (2021).
   Google Scholar
• Hullinger R , PuglielliL. Molecular and cellular aspects of age-related cognitive decline and Alzheimer’s disease. Behav. Brain Res., 322(Pt B), 191–205 (2017).
   PubMedGoogle Scholar
• Young ML , FranklinJL. The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice. Mol. Cell. Neurosci., 101, 103409 (2019).
   PubMed Web of Science ®Google Scholar
• Cavalier AN , ClaytonZS, HuttonDAet al. Accelerated aging of the brain transcriptome by the common chemotherapeutic doxorubicin. Exp. Gerontol., 152, 111451 (2021).
   PubMed Web of Science ®Google Scholar
• Hirai K , AlievG, NunomuraAet al. Mitochondrial abnormalities in Alzheimer’s disease. J. Neurosci., 21(9), 3017–3023 (2001).
   PubMed Web of Science ®Google Scholar
• Hajjar I , HayekSS, GoldsteinFC, MartinG, JonesDP, QuyyumiA. Oxidative stress predicts cognitive decline with aging in healthy adults: an observational study. J. Neuroinflamm., 15(1), 17 (2018).
   PubMedGoogle Scholar
• Mecocci P , PolidoriMC. Antioxidant clinical trials in mild cognitive impairment and Alzheimer’s disease. Biochim. Biophys. Acta, 1822(5), 631–638 (2012).
   PubMed Web of Science ®Google Scholar
• Wichmann MA , CruickshanksKJ, CarlssonCMet al. Long-term systemic inflammation and cognitive impairment in a population-based cohort. J. Am. Geriatr. Soc., 62(9), 1683–1691 (2014).
   PubMed Web of Science ®Google Scholar
• Vivek S , NelsonHH, PrizmentAE, FaulJ, CrimminsEM, ThyagarajanB. Cross sectional association between cytomegalovirus seropositivity, inflammation and cognitive impairment in elderly cancer survivors. Cancer Cause Control, 33(1), 81–90 (2022).
   PubMed Web of Science ®Google Scholar
• Calsolaro V , EdisonP. Neuroinflammation in Alzheimer’s disease: current evidence and future directions. Alzheimers Dement., 12(6), 719–732 (2016).
   PubMed Web of Science ®Google Scholar
• Ogrodnik M , EvansSA, FielderEet al. Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell, 20(2), e13296 (2021).
   PubMed Web of Science ®Google Scholar
• Yabluchanskiy A , TarantiniS, BalasubramanianPet al. Pharmacological or genetic depletion of senescent astrocytes prevents whole brain irradiation-induced impairment of neurovascular coupling responses protecting cognitive function in mice. Geroscience, 42(2), 409–428 (2020).
   PubMed Web of Science ®Google Scholar
• Bussian TJ , AzizA, MeyerCF, SwensonBL, van DeursenJM, BakerDJ. Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature, 562(7728), 578–582 (2018).
   PubMed Web of Science ®Google Scholar
• Poole DC , BehnkeBJ, MuschTI. The role of vascular function on exercise capacity in health and disease. J. Physiol., 599(3), 889–910 (2021).
   PubMed Web of Science ®Google Scholar
• Giza DE , IliescuG, HassanS, MarmagkiolisK, IliescuC. Cancer as a risk factor for cardiovascular disease. Curr. Oncol. Rep., 19(6), 39 (2017).
   PubMed Web of Science ®Google Scholar
• Darby SC , McGaleP, TaylorCW, PetoR. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol., 6(8), 557–565 (2005).
   PubMed Web of Science ®Google Scholar
• Ponnusamy L , MahalingaiahPKS, SinghKP. Treatment schedule and estrogen receptor-status influence acquisition of doxorubicin resistance in breast cancer cells. Eur. J. Pharm. Sci., 104, 424–433 (2017).
   PubMed Web of Science ®Google Scholar
• Pritchard JE , DillonPM, ConawayMR, SilvaCM, ParsonsSJ. A mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer model. Oncology, 83(6), 305–320 (2012).
   PubMed Web of Science ®Google Scholar
• Kohli S , GriggsJJ, RoscoeJAet al. Self-reported cognitive impairment in patients with cancer. J. Oncol. Pract., 3(2), 54–59 (2007).
   PubMedGoogle Scholar
• Philpot RM , FickenM, WeckerL. Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice. Behav. Brain Res., 307, 165–175 (2016).
   PubMed Web of Science ®Google Scholar
• Stachenfeld NS , MazureCM. Precision medicine requires understanding how both sex and gender influence health. Cell, 185(10), 1619–1622 (2022).
   PubMed Web of Science ®Google Scholar
• Santos JD , Oliveira-NetoJT, BarrosPRet al. Th17 cell-linked mechanisms mediate vascular dysfunction induced by testosterone in a mouse model of gender-affirming hormone therapy. Am. J. Physiol. Heart Circ. Physiol., 323(2), H322–H335 (2022).
   PubMed Web of Science ®Google Scholar
• Yuan C , ParekhH, AllegraC, GeorgeTJ, StarrJS. 5-FU induced cardiotoxicity: case series and review of the literature. Cardiooncology, 5, 13 (2019).
   PubMedGoogle Scholar
• Bansal N , AdamsMJ, GanatraSet al. Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors. Cardiooncology, 5, 18 (2019).
   PubMedGoogle Scholar
• Zheng H , DimayugaC, HudaihedA, KatzSD. Effect of dexrazoxane on homocysteine-induced endothelial dysfunction in normal subjects. Arterioscler. Thromb. Vasc. Biol., 22(7), E15–18 (2002).
   PubMed Web of Science ®Google Scholar
• DeVan AE , EskurzaI, PierceGLet al. Regular aerobic exercise protects against impaired fasting plasma glucose-associated vascular endothelial dysfunction with aging. Clin. Sci. (Lond)., 124(5), 325–331 (2013).
   PubMed Web of Science ®Google Scholar
• Durrant JR , SealsDR, ConnellMLet al. Voluntary wheel running restores endothelial function in conduit arteries of old mice: direct evidence for reduced oxidative stress, increased superoxide dismutase activity and down-regulation of NADPH oxidase. J. Physiol., 587(Pt 13), 3271–3285 (2009).
   PubMed Web of Science ®Google Scholar
• Gioscia-Ryan RA , BattsonML, CuevasLM, ZiglerMC, SindlerAL, SealsDR. Voluntary aerobic exercise increases arterial resilience and mitochondrial health with aging in mice. Aging (Albany NY), 8(11), 2897–2914 (2016).
   PubMedGoogle Scholar
• Lesniewski LA , DurrantJR, ConnellMLet al. Aerobic exercise reverses arterial inflammation with aging in mice. Am. J. Physiol. Heart Circ. Physiol., 301(3), H1025–1032 (2011).
   PubMed Web of Science ®Google Scholar
• Lesniewski LA , ZiglerML, DurrantJRet al. Aging compounds western diet-associated large artery endothelial dysfunction in mice: prevention by voluntary aerobic exercise. Exp. Gerontol., 48(11), 1218–1225 (2013).
   PubMed Web of Science ®Google Scholar
• Seals DR , EdwardF. Adolph Distinguished Lecture: the remarkable anti-aging effects of aerobic exercise on systemic arteries. J. Appl. Physiol. (1985), 117(5), 425–439 (2014).
   PubMed Web of Science ®Google Scholar
• Guadagni V , DrogosLL, TyndallAVet al. Aerobic exercise improves cognition and cerebrovascular regulation in older adults. Neurology, 94(21), e2245–e2257 (2020).
   PubMed Web of Science ®Google Scholar
• Nuzum H , StickelA, CoronaM, ZellerM, MelroseRJ, WilkinsSS. Potential benefits of physical activity in MCI and dementia. Behav. Neurol., 2020, 7807856 (2020).
   PubMed Web of Science ®Google Scholar
• Musanti R , ChaoYY, CollinsK. Fitness and quality of life outcomes of cancer survivor participants in a community exercise program. J. Adv. Pract. Oncol., 10(1), 24–37 (2019).
   PubMedGoogle Scholar
• Beaudry RI , LiangY, BoytonSTet al. Meta-analysis of exercise training on vascular endothelial function in cancer survivors. Integr. Cancer Ther., 17(2), 192–199 (2018).
   PubMed Web of Science ®Google Scholar
• Mandolesi L , PolverinoA, MontuoriSet al. Effects of physical exercise on cognitive functioning and wellbeing: biological and psychological benefits. Front. Psychol., 9, 509 (2018).
   PubMed Web of Science ®Google Scholar
• Campbell KL , KamJWY, Neil-SztramkoSEet al. Effect of aerobic exercise on cancer-associated cognitive impairment: a proof-of-concept RCT. Psychooncology, 27(1), 53–60 (2018).
   PubMed Web of Science ®Google Scholar
• Winocur G , WojtowiczJM, HuangJ, TannockIF. Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats. Psychopharmacology (Berl)., 231(11), 2311–2320 (2014).
   PubMed Web of Science ®Google Scholar
• Montaño-Rojas LS , Romero-PérezEM, Medina-PérezC, Reguera-GarcíaMM, de PazJA. Resistance training in breast cancer survivors: a systematic review of exercise programs. Int. J. Environ. Res. Public Health, 17(18), (2020).
   PubMed Web of Science ®Google Scholar
• Lee K , TripathyD, Demark-WahnefriedWet al. Effect of aerobic and resistance exercise intervention on cardiovascular disease risk in women with early-stage breast cancer: a randomized clinical trial. JAMA Oncol., 5(5), 710–714 (2019).
   PubMed Web of Science ®Google Scholar
• Ng AH , Ngo-HuangA, VidalMet al. Exercise barriers and adherence to recommendations in patients with cancer. JCO Oncol. Pract., 17(7), e972–e981 (2021).
   PubMedGoogle Scholar
• Schmitz KH , CourneyaKS, MatthewsCet al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc., 42(7), 1409–1426 (2010).
   PubMed Web of Science ®Google Scholar
• Thong MSY , van NoordenCJF, SteindorfK, ArndtV. Cancer-related fatigue: causes and current treatment options. Curr. Treat. Options Oncol., 21(2), 17 (2020).
   PubMed Web of Science ®Google Scholar
• Stutts WC . Physical activity determinants in adults. Perceived benefits, barriers, and self efficacy. AAOHN J., 50(11), 499–507 (2002).
   PubMedGoogle Scholar
• El Ansari W , LovellG. Barriers to exercise in younger and older non-exercising adult women: a cross sectional study in London, United Kingdom. Int. J. Environ. Res. Public Health, 6(4), 1443–1455 (2009).
   PubMed Web of Science ®Google Scholar
• Craighead DH , HeinbockelTC, FreebergKAet al. Time-efficient inspiratory muscle strength training lowers blood pressure and improves endothelial function, no bioavailability, and oxidative stress in midlife/older adults with above-normal blood pressure. J Am Heart Assoc., 10(13), e020980 (2021).
   PubMed Web of Science ®Google Scholar
• Freeberg K , HeinbockelT, RossmanMet al. High-resistance inspiratory muscle strength training improves cerebrovascular function in midlife/older adults. FASEB J., 35(S1), (2021).
   Google Scholar
• Brunt VE , HowardMJ, FranciscoMA, ElyBR, MinsonCT. Passive heat therapy improves endothelial function, arterial stiffness and blood pressure in sedentary humans. J. Physiol., 594(18), 5329–5342 (2016).
   PubMed Web of Science ®Google Scholar
• Brunt V , RosenbergH, BazzoniAet al. Passive heat therapy lowers systolic blood pressure and improves vascular endothelial function in healthy older adults. FASEB J., 33(S1), 829.822–829.822 (2019).
   Google Scholar
• Von Schulze AT , DengF, MorrisJK, GeigerPC. Heat therapy: possible benefits for cognitive function and the aging brain. J. Appl. Physiol. (1985), 129(6), 1468–1476 (2020).
   PubMed Web of Science ®Google Scholar
• Haendeler J , HoffmannJ, DiehlJFet al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ. Res., 94(6), 768–775 (2004).
   PubMed Web of Science ®Google Scholar
• Matsushita H , ChangE, GlassfordAJ, CookeJP, ChiuCP, TsaoPS. eNOS activity is reduced in senescent human endothelial cells: preservation by hTERT immortalization. Circ. Res., 89(9), 793–798 (2001).
   PubMed Web of Science ®Google Scholar
• Sato I , MoritaI, KajiK, IkedaM, NagaoM, MurotaS. Reduction of nitric oxide producing activity associated with in vitro aging in cultured human umbilical vein endothelial cell. Biochem. Biophys. Res. Commun., 195(2), 1070–1076 (1993).
   PubMed Web of Science ®Google Scholar
• Xin MG , ZhangJ, BlockER, PatelJM. Senescence-enhanced oxidative stress is associated with deficiency of mitochondrial cytochrome c oxidase in vascular endothelial cells. Mech. Ageing Dev., 124(8-9), 911–919 (2003).
   PubMed Web of Science ®Google Scholar
• Yoon HJ , ChoSW, AhnBW, YangSY. Alterations in the activity and expression of endothelial NO synthase in aged human endothelial cells. Mech. Ageing Dev., 131(2), 119–123 (2010).
   PubMed Web of Science ®Google Scholar
• Yousefzadeh MJ , ZhuY, McGowanSJet al. Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine, 36, 18–28 (2018).
   PubMed Web of Science ®Google Scholar
• Verdoorn BP , EvansTK, HansonGJet al. Fisetin for COVID-19 in skilled nursing facilities: senolytic trials in the COVID era. J. Am. Geriatr. Soc., 69(11), 3023–3033 (2021).
   PubMed Web of Science ®Google Scholar
• Chaib S , TchkoniaT, KirklandJL. Cellular senescence and senolytics: the path to the clinic. Nat. Med., 28(8), 1556–1568 (2022).
   PubMed Web of Science ®Google Scholar